# A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye Disease

> **NCT01478555** · PHASE2 · WITHDRAWN · sponsor: **Sun Pharmaceutical Industries Limited**

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** ISV 101

## Key facts

- **NCT ID:** NCT01478555
- **Lead sponsor:** Sun Pharmaceutical Industries Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-01
- **Primary completion:** 2018-07
- **Final completion:** 2019-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Project postponed
- **Last updated:** 2021-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01478555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01478555, "A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye Disease". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01478555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*